Expert answers to key questions on the current treatment of β-thalassemia from a Clinical Care Options (CCO) symposium at ASH 2019
Clinical Care Options (CCO) faculty Hanny Al-Samkari, MD, and Sujit Sheth, MD, provide their thoughts on key studies in nonmalignant hematologic disorders presented at ASH 2019
Download these slides to review the latest clinical data informing optimal management of β-thalassemia, including for new and emerging novel therapies.
CCO faculty Sujit Sheth, MD, provides insight on the optimal management of β-thalassemia, including review of the latest clinical data on new and emerging novel therapies
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.